Nantahala Capital Management »

Senti Biosciences shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Senti Biosciences (SNTI) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Senti Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Senti Biosciences held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Senti Biosciences by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.3M 888k 1.41
2025-06-30 $1.9M 888k 2.11
2025-03-31 $3.0M 888k 3.36

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Edwards Lifesciences Put Option (EW)
Hilton Grand Vacations (HGV)
Establishment Labs Holdings Ord (ESTA)
Peloton Interactive Cl A Com (PTON)
Spdr Series Trust S&p Biotech Put Option (XBI)
Herbalife Com Shs (HLF)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Viatris Call Option (VTRS)
Abivax Sa Sponsored Ads (ABVX)
Xtant Med Hldgs Com New (XTNT)
Fulcrum Therapeutics (FULC)

View all positions for Nantahala Capital Management

Top funds holding Senti Biosciences

NEA Management Company
Nantahala Capital Management
Vanguard Group
Geode Capital Management
Citadel Advisors
XTX Topco
BlackRock
Northern Trust
Two Sigma Investments
State Street Corporation
UBS Group
Tower Research Capital
SBI Securities

View all funds holding Senti Biosciences